Latha Vairavan's most recent trade in Arcutis Biotherapeutics Inc was a trade of 89 Common Stock done at an average price of $14.3 . Disclosure was reported to the exchange on Aug. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Latha Vairavan | SVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.33 per share. | 04 Aug 2025 | 89 | 65,015 (0%) | 0% | 14.3 | 1,275 | Common Stock |
| Arcutis Biotherapeutics Inc | Latha Vairavan | SVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Latha Vairavan | SVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 20,000 | 65,104 (0%) | 0% | 0 | Common Stock |